Target intelligence / Profile preview

WD repeat-containing protein 19 (WDR19)

Target
WDR19
Molecular classification
WD repeat-containing protein (WD repeat protein), Component of intraflagellar transport (IFT) complex A, Other (structural/organellar protein associated with cilia/flagella)
01

Overview

WD repeat-containing protein 19 (WDR19) is a member of the WD-repeat protein family, characterized by conserved repeating units of about 40 amino acids usually bracketed by WD dipeptides, which commonly fold into a beta-propeller structure[4][6]. WDR19 is a critical component of the intraflagellar transport complex A (IFT-A), required for the retrograde movement of materials within cilia and flagella[1][2][3]. Proper function of WDR19 ensures normal cilia formation and maintenance, which is essential for various signaling pathways (notably Sonic Hedgehog signaling), organ development (including kidney, retina, bone), and tissue patterning during embryogenesis[1][2][3]. Mutations in WDR19 disrupt cilia structure and function, causing a spectrum of rare inherited diseases known as ciliopathies, which include cranioectodermal dysplasia, nephronophthisis, retinitis pigmentosa, and other syndromic conditions involving renal, skeletal, and visual organ systems[1][2][3]. WDR19 is not therapeutically targeted by drugs, but pathogenic mutations in this gene are relevant for diagnostic genetics of these rare disorders.

Other names
IFT144intraflagellar transport 144 homologKIAA1638PWDMPFLJ23127ORF26DYF-2Oseg6NPHP13FAP66CFAP66ATD5CED4SPGF72SRTD5WD repeat membrane protein PWDMP
02

Biological functions

Cilium assembly and maintenanceIntraflagellar transport (retrograde transport within cilia)Regulation of Sonic Hedgehog signaling pathwayCellular/organelle biogenesis and maintenanceSignal transduction (through ciliary mediation)
03

Disease associations

Ciliopathies (including cranioectodermal dysplasia, Jeune syndrome, Sensenbrenner syndrome)Renal disease (nephronophthisis)Retinal degeneration (retinitis pigmentosa)Senior-Løken syndromeAsphyxiating thoracic dystrophy

Beyond the preview

Go deeper on WD repeat-containing protein 19 (WDR19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat-containing protein 19 (WDR19).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call